enVVeno Medical Corp
NVNO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001661053
In the last 90 days, enVVeno Medical Corp insiders filed 0 open-market purchases and 1 sale; 17 institutions reported holding it in 13F filings for Q2 2026, worth $953.6K in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in enVVeno Medical Corp as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- +2 vs. Q2 2021
- Shares held
- 841.9K
- −55.8K (−6.2%) vs. Q2 2021
- Total value
- $8.74M
- +$2.57M (+41.7%) vs. Q2 2021
- New holders
- 7
- 1 more added
- Sold out
- 5
- 6 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NVNO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $953.6K |
| Q1 2026 | 17 | $1.02M |
| Q4 2025 | 36 | $2.10M |
| Q3 2025 | 36 | $5.40M |
| Q2 2025 | 37 | $20.3M |
| Q1 2025 | 31 | $9.61M |
| Q4 2024 | 35 | $12.9M |
| Q3 2024 | 36 | $17.5M |
| Q2 2024 | 26 | $17.3M |
| Q1 2024 | 32 | $19.8M |
| Q4 2023 | 30 | $21.8M |
| Q3 2023 | 24 | $10.4M |
| Q2 2023 | 23 | $5.90M |
| Q1 2023 | 18 | $8.50M |
| Q4 2022 | 22 | $8.46M |
| Q3 2022 | 22 | $13.7M |
| Q2 2022 | 21 | $8.11M |
| Q1 2022 | 21 | $13.0M |
| Q4 2021 | 24 | $13.7M |
| Q3 2021 | 16 | $8.74M |
| Q2 2021 | 14 | $6.16M |
| Q1 2021 | 16 | $5.24M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding enVVeno Medical Corp; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 270,390 | $2.81M | 0.00% | +11,710+4.5% | Added |
| ACT Capital Management, LLC | 262,500 | $2.73M | 1.41% | +262,500 | New |
| Morgan Stanley | 171,544 | $1.78M | 0.00% | +171,544 | New |
| L & S Advisors Inc | 30,000 | $311.0K | 0.03% | +30,000 | New |
| BlackRock Inc. | 19,134 | $199.0K | 0.00% | −3,296−14.7% | Reduced |
| State Street Corp | 17,900 | $186.0K | 0.00% | −2,300−11.4% | Reduced |
| Susquehanna Fundamental Investments, LLC | 15,842 | $164.0K | 0.00% | +15,842 | New |
| Northern Trust Corp | 13,906 | $144.0K | 0.00% | −1,454−9.5% | Reduced |
| Marshall Wace, LLP | 12,207 | $127.0K | 0.00% | +12,207 | New |
| Millennium Management LLC | 10,879 | $113.0K | 0.00% | +10,879 | New |
| Bank of America Corp | 9,356 | $97.0K | 0.00% | +9,356 | New |
| Advisor Group Holdings, Inc. | 3,855 | $40.0K | 0.00% | −50−1.3% | Reduced |
| Financial Perspectives, Inc | 3,278 | $34.0K | 0.02% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,041 | $10.0K | 0.00% | −14−1.3% | Reduced |
| UBS Group AG | 1 | $0 | 0.00% | −7,584−100.0% | Reduced |
| Newbridge Financial Services Group, Inc. | 20 | – | – | 00.0% | Unchanged |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −346,885−100.0% | Sold out |
| Worth Venture Partners, LLC | 0 | $0 | 0.00% | −82,886−100.0% | Sold out |
| Kepos Capital LP | 0 | $0 | 0.00% | −71,428−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −63,753−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −184−100.0% | Sold out |